000504.SZ · 南华生物
China A-shares · RS rating 95 · As of 2026-10-14
| Price | 10.25 CNY |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 97 / 93 / 75 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 42 / 40 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +48.0% |
| Distance from 52-week high | +25.4% |
| Market cap (USD) | $581.9M |